NEURODYN LIFE SCIENCES INC.

Profile

Company Names

NEURODYN LIFE SCIENCES INC.
NEURODYN INC.

Addresses

439 HELMCKEN STREET, VANCOUVER, A1 V6B 2E6

1260, 1188 W. GEORGIA STREET, VANCOUVER, A1 V6E 4A2

Phone Numbers

604-684-3323

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

CANADA (FEDERAL LEVEL)

Total Amount Raised:

$3,683,272.00

Number of Funding Rounds:

8
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
8
2015-10-19 
$23,079.00 
$23,079.00 
$0.00 
Equity 
7
2015-09-30 
$650,000.00 
$650,000.00 
$0.00 
Equity 
6
2014-01-07 
$349,185.00 
$349,185.00 
$0.00 
Equity 
5
2013-12-20 
$1,408,880.00 
$1,408,880.00 
$0.00 
Equity 
4
2013-05-28 
$100,280.00 
$100,280.00 
$0.00 
Equity 
3
2013-03-30 
$24,572.00 
$24,572.00 
$0.00 
Equity 
2
2013-01-23 
$1,001,402.00 
$1,001,402.00 
$0.00 
Equity 
1
2012-11-28 
$125,874.00 
$125,874.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
KENNETH 
A. 
CAWKELL 
EXECUTIVE OFFICER, DIRECTOR
ROBERT 
 
CERVELLI 
DIRECTOR
ROBERT 
L. 
CERVELLI 
DIRECTOR
SCOTT 
 
HOMENICK 
EXECUTIVE OFFICER
DENIS 
 
KAY 
EXECUTIVE OFFICER, DIRECTOR
DENIS 
G. 
KAY 
EXECUTIVE OFFICER, DIRECTOR
ALFRED 
 
MAELICKE 
DIRECTOR
MADOLYN 
 
MERTZ 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-10-19 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-09-30 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-09-30 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-12-20 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-12-20 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-01-07 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-12-20 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-05-28 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-03-30 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-01-23 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-11-28 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#